The results of the survey of patients who underwent COVID-19
https://doi.org/10.25789/YMJ.2022.78.18
Abstract
According to some data people who have recovered from COVID-19 often have undesirable consequences of a new disease - post-covid syndrome. We conducted a study of the health status of people who had a coronavirus infection.
Our results showed that after 8 months, people who recovered from COVID-19 complain about the symptoms of post-COVID syndrome. At the same time, the most common clinical manifestations were disturbance (50.9%), arterial hypertension (47.7%), weakness (33.5%), dizziness (32.9%), shortness of breath (27.7%), headaches (24.5%), disorders of the gastrointestinal tract (diarrhea, abdominal pain) (18.7%). Our statistical analysis showed a significant dependence of the increase in the frequency of clinical manifestations: high blood pressure (it was 1.7 times higher), depending on the degree of lung damage.
About the Authors
V. M. Nikolaev
Yakut Scientific Center of Complex Medical Problems
Russian Federation
Russian Federation
Nikolaev Vyacheslav Mikhailovich – Ph.D
E. K. Rumyantsev
Arctic Medical Center YSC CMP
Russian Federation
Russian Federation
Rumyantsev Egor Konstantinovich – junior resaercher
S. I. Sofronova
Arctic Medical Center YSC CMP
Russian Federation
Russian Federation
Sofronova Sargylana Ivanovna – Ph.D, Management Department
S. D. Efremova
Arctic Medical Center YSC CMP
Russian Federation
Russian Federation
EfremovaSvetlana Dmitrievna – junior researcher
S. N. Lekhanova
Medical Institute of M.K. Ammosov NEFU
Russian Federation
Russian Federation
Lekhanova Sargylana Nikolaevna – Candidate of medical sciences, Associate Professor
References
1. Akter F, Mannan A, Mehedi HMH, et al. Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes MetabSyndr. 2020;14(6):2031-2038. doi:10.1016/j.dsx.2020.10.016
2. Angeli F, Reboldi G, Trapasso M, Verdecchia P. Ipertensione dopo vaccinazione anti-COVID-19 [Hypertension after COVID-19 vaccination]. G Ital Cardiol (Rome). 2022;23(1):10-14. doi:10.1714/3715.37055
3. Daskaya H, Yilmaz S, Uysal H, et al. Usefulness of oxidative stress marker evaluation at admission to the intensive care unit in patients with COVID-19. J Int Med Res. 2021;49(7):3000605211027733. doi:10.1177/03000605211027733
4. Galanopoulos M, Gkeros F, Doukatas A, Karianakis G, Pontas C, Tsoukalas N, Viazis N, Liatsos C, Mantzaris GJ. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579. PMID: 32884218; PMCID: PMC7445869.
5. Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6. doi:10.1016/j.jinf.2020.08.029
6. Halliwell, B. and Gutteridge, J.M.C. (2015) Free Radicals in Biology and Medicine. 5th Edition, Oxford University Press, New York. http://dx.doi.org/10.1093/acprof:oso/9780198717478.001.0001
7. Karkhanei B, TalebiGhane E, Mehri F. Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with COVID-19. New Microbes New Infect. 2021;42:100897. doi:10.1016/j.nmni.2021.100897
8. McCarthy CG, Wilczynski S, Wenceslau CF, Webb RC. A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications. Vascul Pharmacol. 2021;137:106826. doi:10.1016/j.vph.2020.106826
9. Mehri F, Rahbar AH, Ghane ET, Souri B, Esfahani M. The comparison of oxidative markers between Covid-19 patients and healthy subjects [published online ahead of print, 2021 Jun 7]. Arch Med Res.2021; S0188-4409(21)00126-0. doi:10.1016/j.arcmed.2021.06.004
10. Pierce, Janet D.; Shen, Qiuhua; Cintron, Samantha A.; Hiebert, John B. Post-COVID-19 Syndrome, Nursing Research: October
11. , 2021 - Volume - Issue - doi: 10.1097/NNR.0000000000000565 11. Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol. 2020 Jul;215(1):87-93. doi: 10.2214/AJR.20.23034. Epub 2020 Mar 14. PMID: 32174129.
12. Shen ZJ, Lu N, Gao LL, Lv J, Luo HF, Jiang JF, Xu C, Li SY, Mao JJ, Li K, Xu XP, Lin B. Initial chest CT findings in COVID-19: correlation with clinical features. J Zhejiang UnivSci B. 2020 Aug.;21(8):668-672. doi: 10.1631/jzus. B2000133. PMID: 32748582; PMCID: PMC7237343.
13. Sudre, C.H., Murray, B., Varsavsky, T. et al. Attributes and predictors of long COVID. Nat Med 27, 626–631 (2021). https://doi.org/10.1038/s41591-021-01292-y
14. Silvagno F, Vernone A, Pescarmona GP. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Antioxidants (Basel). 2020;9(7):624. Published 2020 Jul 16. doi:10.3390/antiox9070624
15. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94:91-95. doi:10.1016/j.ijid.2020.03.017
Review
For citations:
Nikolaev V.M., Rumyantsev E.K., Sofronova S.I., Efremova S.D., Lekhanova S.N. The results of the survey of patients who underwent COVID-19. Yakut Medical Journal. 2022;(2):68-71. https://doi.org/10.25789/YMJ.2022.78.18
Views:
25
Email this article 